The SIBO diagnostics market was valued at US$ 138,324.23 thousand in 2020, and it is projected to reach US$ 194,604.51 thousand by 2028; it is expected to grow at a CAGR of 4.4% from 2021 to 2028. Small intestinal bacterial overgrowth (SIBO) is commonly seen in the presence of one or more predisposing conditions. It varies highly based on the underlying disorders and microbiota characteristics of patients and organisms. SIBO results in gastrointestinal IBS-like symptoms, which could be asymptomatic. In worse cases, it may result in real malabsorption syndrome. Get sample PDF Copy at: https://www.theinsightpartners.com/sample/TIPRE00020544/ ?utm_source=FreePlatform&utm_medium=10381